John Donaubauer has spent his 25-year career involved in almost all aspects of API commercial process development. Donaubauer began his career with Ash Stevens, Inc in 1983 and moved to Abbott Laboratories in 1987. While at Abbott John has held roles in biocide discovery, chemical process development for generic products, and analytical development for generic and ethical pharmaceuticals. John also has held management positions in the commercial process development, program management, API commercial supply chain development, and API CMC technical writing organizations. John has been actively involved with both ISPE and PhRMA groups in the areas of QbD and Q11.